Updated Jul 16, 2026
Short Bartie Wendy has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $17K.

Wendy Short Bartie is an executive vice president of Corporate Affairs at Bristol-Myers Squibb, a leading biopharmaceutical company. She has been involved in the company's strategic communications and public affairs efforts.
| Role | EVP, Corporate Affairs |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-05 | BMY | BRISTOL MYERS SQUIBB CO | F — Tax withholding / forfeiture | 3.9K | $54.72 | $212K |
| 2026-06-05 | BMY | BRISTOL MYERS SQUIBB CO | M — Option exercise | 8.0K | $0.00 | |
| 2026-03-12 | BMY | BRISTOL MYERS SQUIBB CO | F — Tax withholding / forfeiture | 828 | $60.13 | $50K |
| 2026-03-12 | BMY | BRISTOL MYERS SQUIBB CO | J — Other acquisition / disposition | 2.2K | $0.00 | |
| 2026-03-12 | BMY | BRISTOL MYERS SQUIBB CO | M — Option exercise | 4.5K | $0.00 | |
| 2026-03-12 | BMY | BRISTOL MYERS SQUIBB CO | F — Tax withholding / forfeiture | 242 | $60.13 | $15K |
| 2026-03-12 | BMY | BRISTOL MYERS SQUIBB CO | J — Other acquisition / disposition | 81 | $0.00 | |
| 2026-03-12 | BMY | BRISTOL MYERS SQUIBB CO | M — Option exercise | 749 | $0.00 | |
| 2026-03-12 | BMY | BRISTOL MYERS SQUIBB CO | F — Tax withholding / forfeiture | 205 | $60.13 | $12K |
| 2026-03-12 | BMY | BRISTOL MYERS SQUIBB CO | J — Other acquisition / disposition | 72 | $0.00 | |
| 2026-03-12 | BMY | BRISTOL MYERS SQUIBB CO | M — Option exercise | 639 | $0.00 | |
| 2025-09-01 | BMY | BRISTOL MYERS SQUIBB CO | F — Tax withholding / forfeiture | 632 | $47.18 | $30K |
| 2025-09-01 | BMY | BRISTOL MYERS SQUIBB CO | M — Option exercise | 1.2K | $0.00 | |
| 2025-08-02 | BMY | BRISTOL MYERS SQUIBB CO | S — Open-market sale | 378 | $44.23 | $17K |
| 2025-08-02 | BMY | BRISTOL MYERS SQUIBB CO | M — Option exercise | 738 | $0.00 |
Wendy Short Bartie is an executive vice president of Corporate Affairs at Bristol-Myers Squibb, a leading biopharmaceutical company. She has been involved in the company's strategic communications and public affairs efforts.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($17K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Short Bartie Wendy profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.